Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

CARA

Cara Therapeutics Inc

Dec 26 • 04:00PM ET

0.4499

Dollar change -0.0137
Percentage change -2.96	%

Healthcare • Biotechnology • USA • NASD

Peers: GILD VRTX BPMC ARWR SRPT AVXL AMRN NKTR LGND OPK

| Held by: VTI VXF FESM

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.75	Insider Own	16.56%	Shs Outstand	54.85M	Perf Week	71.65%
Market Cap	24.68M	Forward P/E	-	EPS next Y	-	Insider Trans	-0.08%	Shs Float	45.77M	Perf Month	47.70%
Income	-95.53M	PEG	-	EPS next Q	-0.38	Inst Own	24.70%	Short Float	0.72%	Perf Quarter	56.27%
Sales	8.69M	P/S	2.84	EPS this Y	-	Inst Trans	-22.28%	Short Ratio	0.23	Perf Half Y	47.75%
Book/sh	0.01	P/B	34.90	EPS next Y	-	ROA	-114.63%	Short Interest	0.33M	Perf Year	-34.83%
Cash/sh	0.79	P/C	0.57	EPS next 5Y	-	ROE	-221.25%	52W Range	0.23 - 1.15	Perf YTD	-39.45%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-1.20%	ROI	-231.35%	52W High	-60.88%	Beta	0.64
Dividend TTM	-	Quick Ratio	4.71	Sales past 5Y	115.17%	Gross Margin	82.71%	52W Low	99.34%	ATR (14)	0.05
Dividend Ex-Date	-	Current Ratio	4.77	EPS Y/Y TTM	18.99%	Oper. Margin	-948.50%	RSI (14)	75.19	Volatility	38.55% 16.09%
Employees	55	Debt/Eq	61.97	Sales Y/Y TTM	-59.08%	Profit Margin	-1099.76%	Recom	2.60	Target Price	1.00
Option/Short	Yes / Yes	LT Debt/Eq	57.15	EPS Q/Q	55.99%	Payout	-	Rel Volume	0.57	Prev Close	0.46
Sales Surprise	26.80%	EPS Surprise	-40.70%	Sales Q/Q	-47.47%	Earnings	Aug 05	Avg Volume	1.44M	Price	0.45
SMA20	42.89%	SMA50	48.17%	SMA200	-1.15%	Trades		Volume	825,146	Change	-2.96%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-13-24	Downgrade	Stifel	Buy → Hold	$6 → $1
Jun-13-24	Downgrade	Needham	Buy → Hold
Jun-13-24	Downgrade	H.C. Wainwright	Buy → Neutral
Jun-13-24	Downgrade	Canaccord Genuity	Buy → Hold	$10 → $1
Mar-08-23	Downgrade	BofA Securities	Neutral → Underperform	$13 → $6
Mar-08-22	Upgrade	JP Morgan	Neutral → Overweight	$17 → $20
Nov-01-21	Resumed	Canaccord Genuity	Buy	$33
Aug-03-21	Initiated	JP Morgan	Neutral	$16
Apr-21-20	Reiterated	H.C. Wainwright	Buy	$30 → $33
Aug-12-19	Reiterated	H.C. Wainwright	Buy	$31 → $30
May-29-19	Reiterated	Laidlaw	Buy	$26 → $32
Feb-06-19	Resumed	Jefferies	Buy	$22
Jan-15-19	Initiated	BofA/Merrill	Neutral	$19
Sep-21-18	Initiated	Cantor Fitzgerald	Overweight
Sep-13-18	Initiated	Jefferies	Buy	$30
Aug-08-18	Reiterated	Stifel	Buy	$22 → $26
Jun-28-18	Reiterated	H.C. Wainwright	Buy	$24 → $26
Mar-12-18	Resumed	H.C. Wainwright	Buy	$22
Feb-12-18	Upgrade	Janney	Neutral → Buy
Jan-19-18	Initiated	Seaport Global Securities	Buy	$27

Show Previous Ratings

Dec-18-24 07:00AM	Cara Therapeutics and Tvardi Therapeutics Announce Entry into Merger Agreement (GlobeNewswire)
06:45AM	Tessera gets sickle cell funding; Corvus shares slide on eczema data (BioPharma Dive)
Nov-14-24 07:31PM	Cara: Q3 Earnings Snapshot (Associated Press Finance) -5.04%
Aug-15-24 01:55PM	Cara: Q2 Earnings Snapshot (Associated Press Finance)
Jul-11-24 07:00AM	Cara Therapeutics Announces Exploration of Strategic Alternatives (GlobeNewswire) +27.97%
09:51AM	Loading…
Jun-13-24 09:51AM	Chipotle, McDonald's initiated: Wall Street's top analyst calls (The Fly) -34.72%
Jun-12-24 04:01PM	Cara Therapeutics Announces Outcome of Part A of KOURAGE-1 Study Evaluating Oral Difelikefalin in Notalgia Paresthetica (GlobeNewswire)
May-13-24 08:55PM	CARA Stock Earnings: Cara Therapeutics Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:10PM	Cara Therapeutics (CARA) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:07PM	Cara: Q1 Earnings Snapshot (Associated Press Finance)
04:01PM	Cara Therapeutics Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-06-24 07:00AM	Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13, 2024 (GlobeNewswire)
Apr-02-24 07:00AM	Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-07-24 07:00AM	Cara Therapeutics to Host Notalgia Paresthetica (NP) Virtual KOL Event on Wednesday, March 27, 2024 (GlobeNewswire) +6.05%
06:40AM	7 F-Rated Stocks to Sell in March 2024 (InvestorPlace)
09:07AM	Loading…
Mar-05-24 09:07AM	Cara Therapeutics, Inc. (NASDAQ:CARA) Q4 2023 Earnings Call Transcript (Insider Monkey) -8.98%
07:51AM	Q4 2023 Cara Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-04-24 08:51PM	CARA Stock Earnings: Cara Therapeutics Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace) +5.24%
05:10PM	Cara Therapeutics (CARA) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:21PM	Cara: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Feb-12-24 04:01PM	Cara Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024 (GlobeNewswire) -8.54%
Jan-22-24 10:19AM	Cara Layoffs 2024: What to Know About the Latest CARA Job Cuts (InvestorPlace)
07:00AM	Cara Therapeutics Prioritizes Late-Stage Notalgia Paresthetica Program and Extends Cash Runway into 2026 (GlobeNewswire)
Dec-18-23 07:00AM	Cara Therapeutics Announces Outcome from Dose-Finding Part A of KIND 1 Study Evaluating Oral Difelikefalin for Moderate-to-Severe Pruritus in Patients with Atopic Dermatitis (GlobeNewswire) -48.85%
Nov-14-23 11:04AM	Cara Therapeutics, Inc. (NASDAQ:CARA) Q3 2023 Earnings Call Transcript (Insider Monkey) -7.20%
08:48AM	Q3 2023 Cara Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-13-23 06:00PM	Cara (CARA) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks) +12.38%
04:15PM	Cara: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	Cara Therapeutics Reports Third Quarter 2023 Financial Results (GlobeNewswire)
11:38AM	Loading…
Nov-09-23 11:38AM	These Biotech Stocks Could Double Your Money, According To Analysts (Benzinga) -6.72%
Nov-06-23 10:00AM	Earnings Preview: Cara Therapeutics (CARA) Q3 Earnings Expected to Decline (Zacks)
Nov-02-23 07:00AM	Cara Therapeutics Announces up to $40.0 Million Non-Dilutive Financing Agreement with HealthCare Royalty (GlobeNewswire)
Oct-23-23 07:00AM	Cara Therapeutics to Announce Third Quarter 2023 Financial Results on November 13, 2023 (GlobeNewswire)
Sep-25-23 07:00AM	Cara Therapeutics Announces Approval of KORSUVA® IV Injection Syringe in Japan for the Treatment of Pruritus in Hemodialysis Patients (GlobeNewswire)
Sep-05-23 07:00AM	Cara Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire) -10.00%
Aug-10-23 02:53AM	Cara Therapeutics, Inc. (NASDAQ:CARA) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-08-23 05:54AM	Q2 2023 Cara Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-07-23 05:15PM	Cara Therapeutics (CARA) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -5.75%
04:09PM	Cara: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	Cara Therapeutics Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Aug-03-23 07:00AM	Cara Therapeutics Appoints Helen M. Boudreau to Board of Directors (GlobeNewswire)
Aug-02-23 07:00AM	Cara Therapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference (GlobeNewswire)
Jul-24-23 07:00AM	Cara Therapeutics to Announce Second Quarter 2023 Financial Results on August 7, 2023 (GlobeNewswire)
Jun-14-23 01:37PM	The past five years for Cara Therapeutics (NASDAQ:CARA) investors has not been profitable (Simply Wall St.)
Jun-13-23 06:30AM	3 Small-Cap Stocks to Sell in June Before They Crash and Burn (InvestorPlace)
Jun-02-23 06:46PM	Palo Alto Networks Set to S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 (PR Newswire)
Jun-01-23 07:00AM	Cara Therapeutics to Present at the Jefferies Healthcare Conference (GlobeNewswire)
May-30-23 06:34PM	7 Stocks With 1,000% Upside Potential (InvestorPlace) -7.56%
May-25-23 06:40AM	Cara Therapeutics, Inc.'s (NASDAQ:CARA) P/S Is On The Mark (Simply Wall St.) -6.55%
May-18-23 04:53PM	Hero or Zero? 7 Speculative Small-Cap Stocks to Make You Rich or Broke. (InvestorPlace) -8.22%
02:00AM	Kapruvia® (difelikefalin) recommended by England's NICE for the treatment of adults with moderate-to-severe CKD-associated pruritus (PR Newswire)
May-16-23 11:02AM	Q1 2023 Cara Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents) +7.23%
May-15-23 05:15PM	Cara Therapeutics (CARA) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:07PM	Cara: Q1 Earnings Snapshot (AP Finance)
04:01PM	Cara Therapeutics Reports First Quarter 2023 Financial Results (GlobeNewswire)
May-04-23 09:38AM	Cara Therapeutics, Inc. (NASDAQ:CARA) is a favorite amongst institutional investors who own 65% (Simply Wall St.)
May-01-23 07:00AM	Cara Therapeutics to Announce First Quarter 2023 Financial Results on May 15, 2023 (GlobeNewswire)
Apr-26-23 08:00PM	CARA: What does Argus have to say about CARA? (Argus Research)
Apr-10-23 07:00AM	Cara Therapeutics Announces Presentation at the 22nd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Apr-07-23 08:41AM	We're Not Very Worried About Cara Therapeutics' (NASDAQ:CARA) Cash Burn Rate (Simply Wall St.)
Mar-14-23 07:00AM	Cara Therapeutics Releases Inaugural Environmental, Social, and Governance Report (GlobeNewswire)
Mar-11-23 07:19AM	Things Look Grim For Cara Therapeutics, Inc. (NASDAQ:CARA) After Today's Downgrade (Simply Wall St.)
Mar-08-23 06:59AM	Cara Therapeutics, Inc. (NASDAQ:CARA) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-07-23 10:46AM	Metas stock up on report of more layoffs, and WeightWatchers telehealth deal gives it access to promising obesity drug market (MarketWatch) -33.23%
10:02AM	Q4 2022 Cara Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
09:43AM	Cara Therapeutics stock sinks on larger-than-expected Q4 earnings miss (Yahoo Finance Video)
08:05AM	Meta shares rise after new wave of layoffs, WeightWatchers stock makes gains after results and acquisition; Grindrs stock falls after profit drop (MarketWatch)
Mar-06-23 07:39PM	These 2 Stocks Are Plunging After Hours Monday (Motley Fool)
05:15PM	Cara Therapeutics (CARA) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
04:01PM	Cara Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire)
Feb-27-23 10:00AM	Will Cara Therapeutics (CARA) Report Negative Earnings Next Week? What You Should Know (Zacks)
Feb-21-23 07:00AM	Cara Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023 (GlobeNewswire)
Feb-15-23 05:11AM	Cara Therapeutics, Inc. (NASDAQ:CARA) Analysts Just Cut Their EPS Forecasts Substantially (Simply Wall St.)
Feb-08-23 05:00PM	Cara Therapeutics Announces Results from the KOMFORT Phase 2 Trial of Oral Difelikefalin for the Treatment of Pruritus in Notalgia Paresthetica Published in the New England Journal of Medicine (GlobeNewswire)
Jan-17-23 07:00AM	Cara Therapeutics to Host Capital Markets Day on Thursday, February 16, 2023 (GlobeNewswire)
Jan-03-23 07:00AM	Cara Therapeutics Announces Presentation at the 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-29-22 05:53AM	Cara Therapeutics (NASDAQ:CARA shareholders incur further losses as stock declines 8.8% this week, taking three-year losses to 35% (Simply Wall St.) +8.61%
Nov-29-22 07:30AM	KemPharm Announces Appointment of Christopher Posner as New Independent Director (GlobeNewswire)
Nov-09-22 06:08AM	Cara Therapeutics Third Quarter 2022 Earnings: Beats Expectations (Simply Wall St.)
Nov-07-22 05:35PM	Cara Therapeutics (CARA) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:01PM	Cara Therapeutics Reports Third Quarter 2022 Financial Results (GlobeNewswire)
Nov-04-22 08:46AM	Why Cara Therapeutics (CARA) Might Surprise This Earnings Season (Zacks)
Nov-03-22 07:00AM	Cara Therapeutics Announces Appointment of Lisa von Moltke, M.D., to its Board of Directors (GlobeNewswire)
Nov-02-22 10:01AM	Analysts Estimate Affimed N.V. (AFMD) to Report a Decline in Earnings: What to Look Out for (Zacks) -5.80%
07:00AM	Cara Therapeutics to Present at Upcoming Investor Conferences (GlobeNewswire)
Oct-31-22 10:00AM	Cara Therapeutics (CARA) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks)
Oct-30-22 08:51AM	Cara Therapeutics, Inc. (NASDAQ:CARA) is a favorite amongst institutional investors who own 67% (Simply Wall St.)
Oct-24-22 07:00AM	Cara Therapeutics to Announce Third Quarter 2022 Financial Results on November 7, 2022 (GlobeNewswire)
Oct-18-22 09:55AM	Wall Street Analysts See a 133% Upside in Cara (CARA): Can the Stock Really Move This High? (Zacks)
Oct-10-22 04:05PM	SWK Holdings' Subsidiary, Enteris BioPharma, Receives $5 Million Milestone Payment from Cara Therapeutics (PR Newswire)
Sep-28-22 07:00AM	Cara Therapeutics Announces Difelikefalin (KORSUVA®) Injection New Drug Application Has Been Submitted in Japan (GlobeNewswire)
Sep-20-22 09:47AM	Here's Why We're Not Too Worried About Cara Therapeutics' (NASDAQ:CARA) Cash Burn Situation (Simply Wall St.)
Sep-12-22 07:00AM	Cara Therapeutics Appoints Ryan Maynard as Chief Financial Officer (GlobeNewswire)
Sep-08-22 02:27PM	Cara Therapeutics Presents Results of Oral Difelikefalin In Painful Itching Disorder (Benzinga)
08:15AM	Cara Therapeutics Presents Late-Breaking Results of the KOMFORT Phase 2 Trial of Oral Difelikefalin for Pruritus in Notalgia Paresthetica at the 31st EADV Congress (GlobeNewswire)
Sep-06-22 07:00AM	Cara Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference (GlobeNewswire)
Aug-24-22 07:00AM	Cara Therapeutics to Host Virtual Notalgia Paresthetica Event on September 20, 2022 (GlobeNewswire)
Aug-22-22 07:00AM	Cara Therapeutics Announces KOMFORT Data Accepted for Late-Breaking Presentation at the 31st EADV Congress (GlobeNewswire)
Aug-19-22 01:00AM	Kapruvia® approved in Switzerland with additional regulatory decisions expected in H2 2022 (GlobeNewswire)

CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs). Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain. The company was founded by Derek T. Chalmers, Michael E. Lewis, and Frederique Menzaghi on July 2, 2004 and is headquartered in Stamford, CT.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Posner Christopher	PRESIDENT AND CEO	Nov 04 '24	Sale	0.29	3,668	1,064	168,768	Nov 06 04:51 PM
Posner Christopher	PRESIDENT AND CEO	Aug 01 '24	Sale	0.35	4,149	1,452	172,436	Aug 02 04:05 PM
Posner Christopher	PRESIDENT AND CEO	May 02 '24	Sale	0.75	3,936	2,952	176,585	May 06 04:15 PM
Goncalves Joana	CHIEF MEDICAL OFFICER	Apr 05 '24	Sale	0.83	2,753	2,285	53,365	Apr 09 04:22 PM
Terrillion Scott	SEC'Y; CHIEF COMPLIANCE & G.C.	Apr 05 '24	Sale	0.83	2,753	2,285	88,247	Apr 09 04:21 PM
Terrillion Scott	SEC'Y; CHIEF COMPLIANCE & G.C.	Feb 29 '24	Sale	0.89	3,293	2,931	91,000	Mar 04 04:24 PM
Posner Christopher	PRESIDENT AND CEO	Feb 29 '24	Sale	0.89	5,834	5,192	180,521	Mar 04 04:19 PM
Goncalves Joana	CHIEF MEDICAL OFFICER	Feb 29 '24	Sale	0.89	3,293	2,931	56,118	Mar 04 04:13 PM
Posner Christopher	PRESIDENT AND CEO	Feb 08 '24	Sale	0.53	35,575	18,855	186,355	Feb 12 05:10 PM
Posner Christopher	PRESIDENT AND CEO	Feb 01 '24	Sale	0.55	4,981	2,740	221,930	Feb 05 04:26 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CARA

Cara Therapeutics Inc

Upgrade your FINVIZ experience